Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Boston Medical Group vs Harper Meds

Boston Medical Group
Graded #113

Lower grade

vs+2.299999999999997
Harper Meds
Graded #82

Higher grade

The verdict

Harper Meds takes it — 72.2/100 to 69.9/100.

Harper Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. DTC telehealth weight-loss program (Nexus Health Solutions LLC) offering flat-rate compounded semaglutide and tirzepatide, with the consultation, prescription, medication, and shipping bundled into one…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
86
86
Dose & formulationHarper Meds +20
52
72
Clinical oversightBoston Medical Group +15
89
74
Labs & monitoringEven
53
53
FulfillmentHarper Meds +11
65
76
Contract termsEven
55
55
Boston Medical Group · left barHarper Meds · right bar

The numbers

MetricBoston Medical GroupHarper Meds
WeighScore69.9/10072.2/100
GradeCC
Scorecard rank#113#82
Semaglutide$66/mo (starting dose, compounded)$149/mo
TirzepatideNot disclosed$196/mo
Coverage7 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Boston Medical Group

Graded #113 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
Harper Meds

Graded #82 · C

Strengths

  • Flat pricing — same cost at every dose, no escalation as you titrate up
  • All-inclusive: doctor consultation, prescription, medication, and free shipping in one price
  • LegitScript-certified; prescriptions reviewed by US-licensed M.D.s
  • Offers both compounded semaglutide ($149/mo) and tirzepatide ($196/mo)

Where it loses points

  • Membership fee is non-refundable once paid
  • Partner pharmacy is not publicly named
  • State availability not published (limited to 'certain states')

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard